4.5 Article

The 2016 Lifetime Immunization Schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages

期刊

HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 13, 期 11, 页码 2531-2537

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2017.1366394

关键词

vaccines; immunization; life course vaccination; adults' vaccination; scientific societies

资金

  1. Sanofi Pasteur MSD
  2. MSD
  3. GSK
  4. Pfizer
  5. Seqiros

向作者/读者索取更多资源

Medical scientific societies have the core mission of producing, pooling and disseminating solid and updated scientific information. We report the successful experience of the partnership of four national Medical Scientific Societies active in Italy in producing scientific advice on vaccines and vaccination. In particular, i) the Italian Society of Hygiene, Preventive Medicine and Public Health; SitI, ii) the Italian Society of Paediatrics; SIP, iii) the Italian Federation of General Practitioners; FIMP, and iv) the Italian Federation of General Medicine FIMMG) have worked together since 2012 to produce shared evidence-based recommendations on vaccination schedules, namely the Lifetime Immunization Schedule which introduced for the first time in Italy a life-course approach to vaccination. The 2014 edition of the Lifetime Immunization Schedule was used as a basis to develop the 2017-2019 Italian National Prevention Plan, approved by The Italian Ministry of Health in February 2017. In this report, we present the structure, content and supporting evidence of the new 2016 Lifetime Immunization Schedule and we expand on the influential role of medical scientific societies in researching and advocating for effective and safe vaccination programmes' implementation at the national level.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据